Navneet Updhyay, MS, PhD (he/him/his)

Eli Lilly and Company

Poster(s):

• P2132 - Treatment Persistence and Augmentation Differences Across Second-Line Treatment Strategies Among TNFi Experienced Ulcerative Colitis Patients: TNFi Cyclers vs MOA Switchers
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT